• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-A12B filed by Envela Corporation

    5/14/25 5:03:19 PM ET
    $ELA
    Consumer Specialties
    Consumer Discretionary
    Get the next $ELA alert in real time by email
    8-A12B 1 ela-20250514x8a12b.htm 8-A12B

    ​

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    _____________________

     

    FORM 8-A

    _____________________

     

    For Registration of Certain Classes of Securities

     

    Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934

    ​

    Graphic

     

    ​

    ​

    ​

    Envela Corporation

    ​

    ​

    (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

    ​

    ​

    Nevada

    88-0097334

    (State or other jurisdiction of incorporation or organization)

    (I.R.S. Employer Identification No.)

    ​

     

    ​

    ​

    1901 Gateway Drive, Suite 100, Irving, Texas 75038

    ​

    ​

    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

    ​

    ​

    ​

    ​

    ​

    Securities registered pursuant to Section 12(b) of the Act:

    ​

    ​

    ​

    ​

    ​

    ​

    Title of Each Class

        

    Name of Exchange on which Registered

    Common Stock, par value $0.01 per share

    ​

    NYSE Texas, Inc.

     

    ​

    ​

    ​

    If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

    ​

    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

     

    If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

     

    Securities Act registration statement or Regulation A offering statement file number to which this form relates: N/A

     

    Securities to be registered pursuant to Section 12(g) of the Act: None 

     

    ​

    ​


    EXPLANATORY NOTE

    ​

    The following description of the common stock, par value $.01 per share (“Common Stock”) of Envela Corporation (the “Company”) is filed with the United States Securities and Exchange Commission (the “Exchange”) in connection with the dual listing of the Common Stock with NYSE Texas, Inc. (the “NYSE Texas”).

    Item 1. Description of Registrant’s Securities to be Registered.

    The description of the Common Stock contained in Exhibit 4.2, Description of Capital Stock, which was originally filed with the Exchange on March 16, 2022, and incorporated by reference into the Company’s 2024 Annual Report on Form 10-K, to which this Form 8-A relates, is incorporated in reference

    Item 2. Exhibits.

    ​

    Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed, because no other securities of the Registrant are registered on the NYSE Texas, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    2

    ​


    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

    ​

    By:

    /s/ John R. Loftus

     

     

    John R. Loftus

     

     

     

    Chief Executive Officer

     

     

     

     

     

    Date:   May 14, 2025

     

     

    ​

    3

    ​


    Get the next $ELA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ELA

    DatePrice TargetRatingAnalyst
    7/28/2021$10.00Buy
    Lake Street
    More analyst ratings